Integrated DNA Technologies absorbs ArcherDX tech, Boulder facility in Invitae firesale

BOULDER — A little more than two years after California genetics-testing company Invitae Corp. (NYSE: NVTA) bought ArcherDX Inc., a Boulder developer of genetic assays for cancer patients, for $1.4 billion, some of the company’s technology and its local manufacturing, research and development facility has again changed hands — this time for roughly one-thirtieth the price. 

Iowa-headquartered Integrated DNA Technologies Inc. completed a $48 million deal this week to absorb Archer’s trademarked next-generation sequencing research assays, also known as NGS or research-use only kitted solutions, and the company’s 55th Street operations.

IDT, which has facilities and people in California, Michigan, North Carolina,…